Device validation study for detecting likely presnce of COVID-19
Not Applicable
Completed
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2021/09/036489
- Lead Sponsor
- Cellular and Molecular Platforms
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 656
Inclusion Criteria
Male or female patients, 18 years of age and over.
Patients able to read, understand and sign the Informed Consent Form.
Newly diagnosed COVID 19 Patients.
Exclusion Criteria
Patients less than 18 years of age
Pregnant females.
Asymptomatic patients attending isolation ward for COVID testing
Patients on ventilators support
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Validation of the SWAASA AI Platform in detecting likely presence of COVID-19 by comparing with the final clinical diagnosis based on test results of a standard reference test or tests.Timepoint: 5 months
- Secondary Outcome Measures
Name Time Method Evaluate the effectiveness of Swaasa AI platform in detecting COVID-19 in a primary health care settingTimepoint: 2 months